Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Schizophrenia

Free Subscription 31.10.2022 1 Biol Psychiatry 1 J Clin Psychopharmacol 1 J Neuropsychol 2 Mol Psychiatry 2 Psychol Med 5 Schizophr Res

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Biol Psychiatry

1. KETCHESIN KD, Zong W, Hildebrand MA, Scott MR, et al
   Diurnal Alterations in Gene Expression Across Striatal Subregions in Psychosis.
   Biol Psychiatry. 2022 Aug 24. pii: S0006-3223(22)01522.
   PubMed         Abstract available
   
   

   
   J Clin Psychopharmacol

2. DING J, Zhang Y, Zhang Y, Yang L, et al
   Effects of Age, Sex, and Comedication on the Plasma Concentrations of Olanzapine in Chinese Patients With Schizophrenia Based on Therapeutic Drug Monitoring Data.
   J Clin Psychopharmacol. 2022 Oct 25. pii: 00004714-990000000-00067.
   PubMed         Abstract available
   
   

   
   J Neuropsychol

3. IKEDA N, Yamada S, Yasuda K, Uenishi S, et al
   Structural connectivity between the hippocampus and cortical/subcortical area relates to cognitive impairment in schizophrenia but not in mood disorders.
   J Neuropsychol. 2022 Oct 28. doi: 10.1111/jnp.12298.
   PubMed         Abstract available
   
   

   
   Mol Psychiatry

4. WOLF G, Singh S, Blakolmer K, Lerer L, et al
   Could psychedelic drugs have a role in the treatment of schizophrenia? Rationale and strategy for safe implementation.
   Mol Psychiatry. 2022 Oct 24. pii: 10.1038/s41380-022-01832.
   PubMed         Abstract available
   
   
5. TRINDADE P, Nascimento JM, Casas BS, Monteverde T, et al
   Induced pluripotent stem cell-derived astrocytes from patients with schizophrenia exhibit an inflammatory phenotype that affects vascularization.
   Mol Psychiatry. 2022 Oct 24. pii: 10.1038/s41380-022-01830.
   PubMed         Abstract available
   
   

   
   Psychol Med

6. D'ANDREA G, Lal J, Tosato S, Gayer-Anderson C, et al
   Child maltreatment, migration and risk of first-episode psychosis: results from the multinational EU-GEI study.
   Psychol Med. 2022 Oct 28:1-11. doi: 10.1017/S003329172200335.
   PubMed         Abstract available
   
   
7. GUPTA T, Osborne KJ, Nadig A, Haase CM, et al
   Alterations in facial expressions in individuals at risk for psychosis: a facial electromyography approach using emotionally evocative film clips.
   Psychol Med. 2022 Oct 26:1-10. doi: 10.1017/S0033291722003087.
   PubMed         Abstract available
   
   

   
   Schizophr Res

8. KLINE ER, Thibeau H, Davis BJ, Fenley A, et al
   Motivational interviewing for loved ones: Randomized controlled trial of brief training for first episode psychosis caregivers.
   Schizophr Res. 2022;250:43-49.
   PubMed         Abstract available
   
   
9. WALTHER S, Nadesalingam N, Nuoffer M, Kyrou A, et al
   Structural alterations of the motor cortex and higher order cortical areas suggest early neurodevelopmental origin of catatonia in schizophrenia.
   Schizophr Res. 2022 Oct 20. pii: S0920-9964(22)00374.
   PubMed         Abstract available
   
   
10. GAO YN, Olfson M
    National trends in metabolic risk of psychiatric inpatients in the United States during the atypical antipsychotic era.
    Schizophr Res. 2022;248:320-328.
    PubMed         Abstract available
    
    
11. BENAROUS X, Lahaye H, Cottin G, Garny de la Riviere S, et al
    Trends in the use of long-acting injectable antipsychotics in children and adolescents in France between 2014 and 2018.
    Schizophr Res. 2022;248:231-232.
    PubMed        
    
    
12. KESHAVAN MS, Bishop DL, Coconcea C, Bishop JR, et al
    Clozapine, an update.
    Schizophr Res. 2022;248:168-170.
    PubMed        
    
    

Thank you for your interest in scientific medicine.

AMEDEO Schizophrenia is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: